Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Atyr Pharma Inc (LIFE)

Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Atyr Pharma: Q1 Earnings Snapshot

Atyr Pharma: Q1 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q4 Earnings Snapshot

Atyr Pharma: Q4 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q3 Earnings Snapshot

Atyr Pharma: Q3 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q2 Earnings Snapshot

Atyr Pharma: Q2 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q1 Earnings Snapshot

Atyr Pharma: Q1 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q4 Earnings Snapshot

Atyr Pharma: Q4 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q3 Earnings Snapshot

Atyr Pharma: Q3 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
aTyr Pharma Receives FDA Fast Track Designation for Efzofitimod (ATYR1923) for Treatment of Pulmonary Sarcoidosis

Company is investigating efzofitimod in global pivotal Phase 3 EFZO-FITâ„¢ study in pulmonary sarcoidosis patients...

LIFE : 1.9000 (+2.70%)
Love Hemp Group PLC Announces Directorate Changes and Trading Suspension Update

LONDON, UK / ACCESSWIRE / July 8, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF) the brand-led consumer goods company focussed on CBD health and wellness solutions, gives an update regarding its Board...

WRHLF : 0.0001 (unch)
LIFE : 1.9000 (+2.70%)
aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment

Poster to be presented at the Keystone Symposia on Tissue Fibrosis and Repair. Second tRNA synthetase receptor identified from company’s platform. ...

LIFE : 1.9000 (+2.70%)

Barchart Exclusives

5 'Pick and Shovel' AI Growth Stocks to Scoop Up Now
With AI demand rising and data centers set for explosive growth, these AI infrastructure providers emerge as prime investment opportunities now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar